Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.

MLA

Tarhini, Ahmad A., et al. “Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 30, no. 23, Dec. 2024, pp. 5333–41. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-24-2768.

APA

Tarhini, A. A., Eroglu, Z., Eljilany, I., Zager, J. S., Gonzalez, R. J., Sarnaik, A. A., Cruse, C. W., Khushalani, N. I., De Aquino, D. B., Abraham, E., Acevedo, D. M., Richards, A., Schell, M. J., Kalos, D., Chen, P.-L., Messina, J. L., Canton, D. A., & Sondak, V. K. (2024). Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 30(23), 5333–5341. https://doi.org/10.1158/1078-0432.CCR-24-2768

Chicago

Tarhini, Ahmad A, Zeynep Eroglu, Islam Eljilany, Jonathan S Zager, Ricardo J Gonzalez, Amod A Sarnaik, Carl Wayne Cruse, et al. 2024. “Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 30 (23): 5333–41. doi:10.1158/1078-0432.CCR-24-2768.